 |
 |
 |
FDA
Home Page | Search FDA Site |
FDA A-Z Index | Contact FDA
November 17, 2005
The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.
Nov. 14 and 15, 2005: Advisory Committee for Pharmaceutical Sciences, Clinical Pharmacology Subcommittee (CDER)
Jeffrey Barrett, Ph.D. (PDF 51KB)
Michael Caldwell, M.D., Ph.D. (1) (PDF 45 KB)
Michael Caldwell, M.D., Ph.D. (2) (PDF 82 KB)
Edmund V. Capparelli, Pharm.D. (1) (PDF 60 KB)
Edmund V. Capparelli, Pharm.D. (2) (PDF 35 KB)
David Z. D'Argenio, Ph.D. (PDF 49 KB)
Marie Davidian, Ph.D. (PDF 49 KB)
David Flockhart, M.D., Ph.D. (PDF 44 KB)
Brian Gage, M.D. (1) (PDF 60 KB)
Brian Gage, M.D. (2) (PDF 47 KB)
Carol Gloff, Ph.D. (PDF 54 KB)
William Jusko, Ph.D. (PDF 54 KB)
Gregory L. Kearns, Pharm.D. (PDF 43 KB)
Howard McLeod, Pharm.D. (1) (PDF 60 KB)
Howard McLeod, Pharm.D. (2) (PDF 62 KB)
Mary Relling, Pharm.D. (PDF 44 KB)
Wolfgang Sadee, Ph.D. (PDF 46 KB)
Nozer D. Singpurwalla, Ph.D. (PDF 46 KB)
Nov. 16, 2005: Cardiovascular and Renal Drugs Advisory Committee (CDER)
David DeMets (PDF 80 KB)
Thomas G. Pickering, M.D. (PDF 64 KB)
Nov. 15 - 18, 2005: Pediatric Advisory Committee (OC)
Paul Boepple, M.D. (PDF 63 KB)
Patricia S. Choban, M.D. (PDF 50 KB)
Thomas H. Inge, M.D., Ph.D. (PDF 58 KB)
Nov. 17, 2005: Vaccines and Related Biological Products Advisory Committee (CBER)
Steven Piantadosi, M.D., Ph.D. (PDF 42 KB)